Table 1 Cohort characteristics
Studies | Cases (F/C) | Mean age (F/C) | Male patient (F/C) | Dosage (ml) | Prophylactic antithrombotic | Reference type | Quality assessment score |
|---|---|---|---|---|---|---|---|
Kim 2012 [11] | 97/99 | 72.7/70.1 | NS | 10 | Aspirin or warfarin, NS | RCT | 6 |
Francesco 2013 [9] | 51/42 | 67.9/70.2 | 24/17 | 10 | LMWH 4,000 IU | RCT | 4 |
Suarez 2014 [10] | 56/52 | 65.9/65.1 | 20/21 | 10 | Enoxaparin, NS | RCT | 6 |
Helito 2013 [12] | 10/10 | 67.8/66.6 | NS | NS | Enoxaparin 40 mg | PCT | 17 |
Comadoll 2012 [13] | 184/165 | NS | 64/54 | 20 | Warfarin 5 mg | CCT | 18 |